Cash Ratio Analysis of Xenon Pharmaceuticals Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Cash Ratio of XENE
Dec-23
58.52
Excellent Cash Ratio
Dec-22
18.13
Excellent Cash Ratio
Growth
222.71
%
Cash Ratio Analysis of Xenon Pharmaceuticals Inc
Cash Ratio of Xenon Pharmaceuticals Inc with value of 58.52 indicates that a company has generated more cash in a period than what is needed to pay off its current liabilities.
Cash Ratio of XENE rose handsomely by 222.71 % this year.
Cash Ratio with value of 58.52 was highest in Year Dec-23 in last Five Years.
Cash Ratio with value of 3.26 was lowest in Year Dec-19 in last Five Years.
Latest Cash Ratio with value of 58.52 is Greater than Average Cash Ratio of 26.08 in last five years.
Other Cash Ratio Related Info of XENE that may interest you.
Xenon Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
XENE38.0739.04 2.48 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents.   more ..
Cash Ratio Formula

Cash Ratio Related Ratios
CurrentRatioQuickRatioDebtToEquityRatio

Tsr Stability Index
Mild Stability
FY - Historical Cash Ratio of Xenon Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Cash Ratio58.5218.1338.5311.973.2628.9610.69
Change222.71 %-52.93 %221.73 %267.47 %-88.75 %170.83 %-41.38 %
You are view first 7 Records. Log in to view all 13 in Premium view
FY Chart of Cash Ratio of Xenon Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)